ANALISIS DRUG RELATED PROBLEMS (DRPs) PENGGUNAAN ANTIPSIKOTIK PADA PASIEN SKIZOFRENIA DI RUMAH SAKIT JIWA PROVINSI LAMPUNG JANUARI-JUNI 2024
DRUG RELATED PROBLEMS (DRPs) ANALYSIS OF ANTIPSYCHOTIC USE IN SCHIZOPHRENIA PATIENTS AT THE MENTAL HOSPITAL OF LAMPUNG PROVINCE JANUARY-JUNE 2024
DOI:
https://doi.org/10.37090/jfl.v14i1.2222Abstract
Schizophrenia is severe mental disorder that affects an individual’s thought, feelings, and behavior. Antipsychotics are the primary treatment for schizophrenia and used for a long preiod of time which increases the risk of Drug Related Problems (DRPs) and cause ineffective therapeutic results. The purpose of this study was to analyze the incidience of DRPs on the use antipsychotic in scizhoprenia patients at The Mental Hospital Of Lampung Province January-June 2024. This research study is a descriptive study with purposive sampling technique. The number of samples used was 86 samples of schizophrenia in patients at Mental Hospital Of Lampung Province in January-June 2024. The results showed that the characteristics of schizophrenia patiens based on gender were 77 men (89,5%) and 9 women (10,5%). Characteristic based on age are26-35 years old 35 people (40,7%). The Characteristics of the most patients occupations were not working 68 people (79,1%). The most prevalent kind of schizophrenia patients was paranoid schizophrenia as 82 cases (94,2%). The most prescribed drugs for schizophrenia patients were risperidone 82 prescriptions, chlorpromazine 70 prescriptions, and trihexyphenidyl 86 prescriptions. The incidence of DRPs in the category of inappropriate drug combinations was 86 cases (100%), drug dose too low was 23 cases (27%), drug dose too high 0%, and inapproprate of drug administration was 0%. The conclusion of this study is the precentage of Drug Related Problems (DRPs) in schizophrenia patients at the Mental Hospital Of Lampung Province is 32%.
Keywords : Antipsychotics, DRPs, Schizophrenia
Downloads
References
[1] Direktorat Pelayanan Kefarmasian. Pedoman Pelayanan Kefarmasian Pada Pasien Gangguan Jiwa. Jakarta: Kementerian Kesehatan Republik Indonesia; 2021.
[2] World Health Organization. Nation for Mental Health. 2022. Schizophrenia.
[3] Kementerian Menteri Kesehatan. Riset Kesehatan Dasar 2018. Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan RI. Jakarta; 2018.
[4] Schwinghammer TL et al. Pharmacotherapy Handbook 11th Edition. United State: McGraw-Hill Education; 2021.
[5] Ratnasari ID. Analisis Drug Related Problems Penggunaan Antipsikotik Pada Penderita Schizophrenia Dewasa Di Rumah Sakit Jiwa X Surabaya. 2018;7(1):721–35.
[6] Pharmaceutical Care Network Europe Association. Classification for Drug Related Problems. 2020.
[7] Rikomah SE. Farmasi Klinik. Yogyakarta: Deepublish; 2019.
[8] Wanda Utami V et al. Profil Drug Related Problems (DRPs) Pada Pasien Skizofrenia Di Instalasi Rawat Inap Rumah Sakit Jiwa Mutiara Sukma Provinsi NTB Tahun 2020. Pharm J Indones. 2022;8(1):87–94.
[9] Chairil, Intan. Faktor–Faktor Resiko Yang Berhubungan Dengan Kejadian Skizofrenia Di Rumah Sakit Jiwa Tampan Pekanbaru. Phot J Sain dan Kesehat. 2021;12(1):34–50.
[10] Elvira SD, Hadisukanto G. Buku Ajar Psikiatri. Jakarta: FK UI; 2017.
[11] Handayani DS et al. Pengaruh Pemberian Kombinasi Antipsikotik Terhadap Efek Samping Sindrom Ekstrapiramidal Pada Pasien Skizofrnia di Rumah Sakit Jiwa Sambang Lihum. Farmaka. 2017;15(3):86–95.
[12] Jusuf H et al. Gambaran Penggunaan Obat Antipsikotik pada Pasien Skizofrenia di Puskesmas Kota Gorontalo. J Syifa Sci Clin Res. 2024;6(1):20–33.
[13] Indriani A et al. Studi Penggunaan Kombinasi Antipsikotik pada Pasien Skizofrenia di Rumah Sakit Yogyakarta. Maj Farmasetika. 2020;4(Suppl 1):201–11.
[14] Drugs.com [Internet]. 2023. Tersedia pada: https://www.drugs.com/
[15] Ramdini DA et al. Potensi Interaksi Obat pada Pasien Skizofrenia di Salah Satu Rumah Sakit Jiwa di Provinsi Jawa Barat. Indones J Clin Pharm. 2018;7(4):280.
[16] Aprilia N et al. Prinsip Tujuh Benar Pemberian Obat: Suatu Studi Kasus. J Ilm Mhs.2022;I:1–8.
